Literature DB >> 8504273

Effect of DMSO exposure without cryopreservation on hematopoietic progenitor cells.

S D Rowley1, G L Anderson.   

Abstract

Colligative cryoprotectants must be non-toxic at the high concentrations required for protection of cells from freeze-injury. Human hematopoietic stem cells are usually cryopreserved in a solution containing 1.6 molal (10% v/v) DMSO. We studied the chemical toxicity of this agent to myeloid and erythroid progenitor cells from healthy donors. No DMSO toxicity was found at concentrations of 5% or 10% at either 4 degrees or 37 degrees C for incubation durations up to 1 h. DMSO at 20% did not decrease the number of progenitor cell-derived colonies per 5 x 10(4) cells cultured, but did result in cell clumping during DMSO washout, resulting in a net loss of progenitor cells. At a concentration of 40% DMSO, a direct toxicity to hematopoietic progenitors was found. Delay in removal of DMSO after thawing of cryopreserved cells for periods up to 1 h was also non-toxic to hematopoietic progenitor cells. Direct addition of DMSO at 1% or 10% final concentration (v/v) to the culture dishes suppressed colony formation. These data suggest that DMSO is not toxic to haematopoietic progenitor cells after short-term exposure at the concentrations used for cryopreservation of marrow and peripheral blood stem cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504273

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

1.  Cryopreservation of Human Stem Cells for Clinical Application: A Review.

Authors:  Charles J Hunt
Journal:  Transfus Med Hemother       Date:  2011-03-16       Impact factor: 3.747

2.  Essential requirements for setting up a stem cell processing laboratory.

Authors:  T Leemhuis; D Padley; C Keever-Taylor; D Niederwieser; T Teshima; F Lanza; C Chabannon; P Szabolcs; A Bazarbachi; M B C Koh
Journal:  Bone Marrow Transplant       Date:  2014-06-16       Impact factor: 5.483

3.  Sand-mediated ice seeding enables serum-free low-cryoprotectant cryopreservation of human induced pluripotent stem cells.

Authors:  Bin Jiang; Weijie Li; Samantha Stewart; Wenquan Ou; Baolin Liu; Pierre Comizzoli; Xiaoming He
Journal:  Bioact Mater       Date:  2021-04-30

4.  Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.

Authors:  Md Nasimuzzaman; Danielle Lynn; Rebecca Ernst; Michele Beuerlein; Richard H Smith; Archana Shrestha; Scott Cross; Kevin Link; Carolyn Lutzko; Diana Nordling; David W Russell; Andre Larochelle; Punam Malik; Johannes C M Van der Loo
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-16       Impact factor: 6.698

5.  Pentaisomaltose, an Alternative to DMSO. Engraftment of Cryopreserved Human CD34+ Cells in Immunodeficient NSG Mice.

Authors:  Jesper Dyrendom Svalgaard; Mehrnaz Safaee Talkhoncheh; Eva Kannik Haastrup; Lea Munthe-Fog; Christian Clausen; Morten Bagge Hansen; Pernille Andersen; Jette Sønderskov Gørløv; Jonas Larsson; Anne Fischer-Nielsen
Journal:  Cell Transplant       Date:  2018-07-30       Impact factor: 4.064

6.  Effect of different freezing rates during cryopreservation of rat mesenchymal stem cells using combinations of hydroxyethyl starch and dimethylsulfoxide.

Authors:  Yahaira Naaldijk; Marek Staude; Viktoriya Fedorova; Alexandra Stolzing
Journal:  BMC Biotechnol       Date:  2012-08-13       Impact factor: 2.563

7.  The Assessment of Parameters Affecting the Quality of Cord Blood by the Appliance of the Annexin V Staining Method and Correlation with CFU Assays.

Authors:  Teja Falk Radke; David Barbosa; Richard Charles Duggleby; Riccardo Saccardi; Sergio Querol; Gesine Kögler
Journal:  Stem Cells Int       Date:  2013-03-07       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.